NCT00398476 - Fluticasone Nasal Spray Patient Preference Study | Biotech Hunter

Enrollment

127

Participants

Timeline

Start Date

December 1, 2006

Primary Completion Date

December 4, 2006

Study Completion Date

December 4, 2006

Conditions

Rhinitis, Allergic, Perennial

Interventions

DRUG

fluticasone propionate (FP)

200 micrograms (mcg); an aqueous suspension of microfine FP

DRUG

fluticasone furoate (FF)

110 mcg; an aqueous suspension containing 0.05% w/w of micronized FF

Trial Locations (14)

GSK Investigational Site, Brick

GSK Investigational Site, Lawrenceville

GSK Investigational Site, Savannah

GSK Investigational Site, Ypsilanti

GSK Investigational Site, Minneapolis

GSK Investigational Site, St Louis

GSK Investigational Site, Rolla

GSK Investigational Site, El Paso

GSK Investigational Site, Denver

GSK Investigational Site, Lakewood

GSK Investigational Site, Long Beach

GSK Investigational Site, San Diego

GSK Investigational Site, Fountain Valley

GSK Investigational Site, Skillman